Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 2No longer available 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Expanded_access 1

Sponsor

Cancer Type

CNS 4

Conditions

Glioblastoma 3Rhabdoid Tumor 1Recurrence 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 165Magnetic Resonance Spectroscopy 130Radiotherapy 95Specimen Handling 80Radiosurgery 60Cyclophosphamide 55pembrolizumab 51Bevacizumab 51Nivolumab 48Radiation 47Carboplatin 34Biopsy 33Irinotecan 29Lomustine 25Etoposide 25Vincristine 23Topotecan 23Ipilimumab 23dinutuximab 21Cisplatin 21Blood Specimen Collection 21fludarabine 19Radiotherapy, Intensity-Modulated 19X-Rays 18Surgical Procedures, Operative 18abemaciclib 16Mental Status and Dementia Tests 16Granulocyte-Macrophage Colony-Stimulating Factor 16Pemetrexed 15atezolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
gallium maltolate × CNS × 1 year × Clear all
NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

Medical College of Wisconsin

Phase EARLY_PHASE1 Not yet recruiting
8 enrolled
CNS

Glioblastoma

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available
CNS

Glioblastoma

NCT07331064 2026-01-09

GABRIEL

Medical College of Wisconsin

Phase 1 Not yet recruiting
15 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma, Recurrence, Rhabdoid Tumor

NCT04319276 2025-11-03

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Medical College of Wisconsin

Phase 1 Active not recruiting
26 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡